7月30日，Glaukos Corp盘中上涨5.21%，报169.765美元/股，成交额2.23亿美元。消息面上，公司于盘后发布第二季度财报，营收与全年指引均大幅超出市场预期，成为推动股价走强的核心催化剂。
数据显示，公司第二季度销售额达1.856亿美元，较市场一致预期的1.509亿美元高出约23%；调整后每股亏损0.14美元，优于预期的0.22美元，亏损幅度同比收窄41.67%。同时，公司将全年销售指引大幅上调至6.8亿至7.0亿美元，远超FactSet此前6.3亿美元的一致预期。这已是公司连续第二个季度营收显著超预期，延续高增态势。此外，Needham将目标价从150美元大幅上调至201美元并维持买入评级，进一步提振市场情绪。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.